-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/teamwork/assemble/assemble-team-facilitator-guide.docx
May 01, 2017 - Work with team members to consider patient risks identified in the Staff Safety Assessment, which is discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritized-research-agenda.pdf
October 01, 2021 - The Stakeholder
5
Panel discussed the questions and provided feedback through a series of virtual
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/recruitment-and-retention-toolkit.pdf
January 01, 2019 - Email a follow-up
summary following each visit to provide clarity about what was discussed, and
as
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - management
and should not be prescribed for its treatment;” however, results from a 2011 survey (discussed
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
January 13, 2015 - APS-DRGs® are based upon the SDRG
research conducted by CMS, but address the limitations discussed above … Figure 1 illustrates the basic differences in structure for the three systems discussed
(CMS DRGs, SDRGs … RESULTS
As discussed above, APS-DRGs® were developed as an extension of the proposed
CMS SDRG model
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
January 13, 2015 - APS-DRGs® are based upon the SDRG
research conducted by CMS, but address the limitations discussed above … Figure 1 illustrates the basic differences in structure for the three systems discussed
(CMS DRGs, SDRGs … II.6
RESULTS
As discussed above, APS-DRGs® were developed as an extension of the proposed
CMS
-
hcup-us.ahrq.gov/db/nation/nis/reports/2004niscomparisonrpt.jsp
May 01, 2016 - NIS-MedPAR Evaluations
As discussed previously, NIS Medicare discharge estimates were higher than MedPAR … Conclusion
Each of the data sources discussed has its strengths and weaknesses, and each may be the … As for which of the data sources discussed is preferable or better, the answer depends on the needs of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - Health Care Program at AHRQ
None of the authors has a financial interest in any of the products discussed … Care Program, it
does not address searching for previously published systematic reviews, which is discussed … reporting of and
more complex search strategies.4-6
Table 1 describes the various search activities discussed
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/ade.pdf
November 11, 2019 - Practice: Deprescribing To Reduce
Polypharmacy in Older Adults
9.2.1 Clinical Outcomes
As previously discussed … group (p<0.001).6 Frankenthal et al. (2017) found that when pharmacists and
prescribing physicians discussed … related to cognitive declines when medications are
reduced and/or eliminated, such findings were not discussed
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024767-yen-final-report-2019.pdf
January 01, 2019 - When asked to describe factors facilitating or hindering their adaptation to various health IT, nurses discussed … Health IT Usage
Nurses also discussed their experiences specifically regarding how various health IT … Participants who hold a leadership role discussed examples of how they
monitor usage in order to improve
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - reviewers will attend a training session where the inclusion and exclusion
criteria will be presented and discussed … Draft summary tables and figures to
be included in the results section of the report will be discussed
-
www.ahrq.gov/sites/default/files/2024-07/zhou-report.pdf
January 01, 2024 - Medication Safety
We also conducted a narrative review that illustrated the fundamentals of NLP and
discussed … frequently reported reactions were more prevalent on social media
(i.e., aspirin-induced hypoglycemia was discussed
-
psnet.ahrq.gov/perspective/conversation-charles-crecelius-md-phd-cmd-and-lori-l-popejoy-phd-rn-faan
October 28, 2020 - We discussed with them the response to the COVID-19 pandemic in long-term care facilities. … KH : Is there anything you would like to bring up that we have not discussed?
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - Determinants
of Health
PRAPARE survey, health
process and outcome metrics
compared by race or SES
As discussed … For each of the
measures discussed above, the frequency, modality, and approach can greatly influence
-
www.ahrq.gov/sites/default/files/2025-03/wears-perry-report.pdf
January 01, 2025 - Results
Only the most salient and illustrative results are discussed in this report, in order to
keep … An additional risk exists in that the patient may be returned to an
abusive situation, as discussed
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-14-attachment-1.pdf
January 01, 2011 - We also discussed creating an outcome measure on symptom reduction but the work group was limited to … Additionally, we discussed forming a measure on
prescribing first line therapy for children other than
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-14-attach-1.pdf
January 01, 2011 - We also discussed creating an outcome measure on symptom reduction but the work group was limited to … Additionally, we discussed forming a measure on
prescribing first line therapy for children other than
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
August 25, 2021 - transient eleva-
tions in liver enzyme or creatine kinase levels is unknown.1,17
In the statin trials discussed … that there were no adverse events.1,17
Multifactorial Dyslipidemia
The 2 behavioral counseling trials discussed
-
www.ahrq.gov/research/findings/final-reports/crcscreeningrpt/crcscreen3.html
April 01, 2018 - intervention evaluation study, practices and patients had to meet the inclusion/exclusion criteria discussed … During our informal conversation with LVHN project staff, we discussed the following topics:
How
-
psnet.ahrq.gov/perspective/long-term-care-and-response-covid-19
October 28, 2020 - We discussed with them the response to the COVID-19 pandemic in long-term care facilities. … KH : Is there anything you would like to bring up that we have not discussed?